Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.8B | 1.7B | 1.7B | 1.9B |
Cost of revenue | 1.4B | 1.4B | 1.4B | 1.5B |
Gross profit | 335M | 304M | 250M | 404M |
Operating expense | ||||
Research & development | 1M | 2M | 1M | 3M |
Selling general and admin | 142M | 144M | 144M | 138M |
Other operating expenses | 11M | 2M | 3M | 1M |
Operating income | 181M | 156M | 102M | 262M |
Non operating interest income | ||||
Income | 5M | 10M | 14M | 13M |
Expense | 66M | 66M | 69M | 67M |
Other income expense | -21M | -26M | -34M | -2M |
Pretax income | 99M | 74M | 13M | 206M |
Tax provision | 16M | -7M | -15M | 33M |
Net income | 83M | 81M | 28M | 173M |
Basic EPS | 0.1 | 0.1 | 0.0 | 0.2 |
Diluted EPS | 0.1 | 0.1 | 0.0 | 0.2 |
Basic average shares | 726.1M | 726.9M | 727.6M | 729.0M |
Diluted average shares | 726.6M | 727.8M | 728.2M | 729.3M |
EBITDA | 292M | 281M | 231M | 391M |
Net income from continuing op. | 83M | 81M | 28M | 173M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |